Venture Capital Funding for Women’s Health Plummets Amid Broader Market Reset, Sparks Strategic Re-evaluation
admin After experiencing a surge to record levels in 2024, venture capital investments in women’s health...
biotech
Massachusetts Biotech Funding Sees Divergent Trends as Early-Stage Investment Wanes Amid Rising China Competition
A recent comprehensive report by MassBio, a prominent trade organization representing the Massachusetts life sciences...
FDA extends review of Capricor cell therapy; Pain drug startup to go public
Washington D.C. – August 24, 2026 – The biopharmaceutical landscape is abuzz with significant regulatory...
Advancing the Fight Against Sarcoma: Immunotherapy’s Evolving Role in a Rare and Complex Cancer
Sarcoma, a rare and complex group of cancers originating in the body’s connective tissues, presents...
Regenxbio’s RGX-121 Gene Therapy for Hunter Syndrome Faces New Clinical Hold Amidst Troubled Regulatory Path
The development journey for RGX-121, Regenxbio’s investigational gene therapy designed as a one-time treatment for...
FDA Grants Accelerated Approval to Tudriqev, Marking a Decade-Plus Milestone in Oncolytic Virus Therapy for Advanced Melanoma
The U.S. Food and Drug Administration (FDA) has announced the accelerated approval of Tudriqev (vusolimogene...
Pharma marketers need a share-of-answer strategy before AI spend
The pharmaceutical marketing landscape is undergoing a profound transformation, driven by the rapid integration of...
Cancer Research Institute Announces 2026 CLIP and Technology Impact Awards, Fueling Next-Generation Immunotherapy Breakthroughs
The Cancer Research Institute (CRI) has proudly announced the recipients of its 2026 Clinic and...
The Hidden Epidemic: Unraveling Lung Cancer in Never-Smokers as a Distinct and Rising Global Health Challenge
For decades, lung cancer has been almost exclusively associated with tobacco use, a perception rooted...
Cancer Research Institute Elevates Next Generation of Scientists with Significant Investment in Immunotherapy Fellowships
The Cancer Research Institute (CRI) has announced the recipients of its Fall 2025 and Spring...
